Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise before surgery may slow cancer growth, small study hints

NCT ID NCT04025229

First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 33 times

Summary

This study tested whether a few sessions of high-intensity interval training (HIIT) before surgery could affect cancer cells in women with endometrial cancer. Thirty women with early-stage disease did 4 to 6 exercise sessions before their scheduled hysterectomy. Researchers then compared tissue samples taken before and after exercise to see if the training reduced markers of cancer cell growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UNC Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, 27599, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

High intensity interval training (HIIT) exercise

What this could lead to

If it works, this could point toward exercise as a way to slow tumor growth before surgery for endometrial cancer.

What could go wrong

This is a very small, early study with only 30 participants and no comparison group. It measures biological markers, not actual cancer outcomes, so results may not lead to a treatment.

Conditions

The condition(s) this trial relates to.

endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.